Trial Profile
A Phase 1 Study of the Effects of Itraconazole on the Pharmacokinetics of ALKS 5461 in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Sep 2018
Price :
$35
*
At a glance
- Drugs Buprenorphine/samidorphan (Primary) ; Itraconazole
- Indications Cocaine-related disorders; Major depressive disorder
- Focus Pharmacokinetics
- Sponsors Alkermes plc
- 01 Sep 2018 Results published in the Clinical Pharmacology in Drug Development
- 11 Dec 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 27 Oct 2014 New trial record